Dexamethasone-sparing on days 2–4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial)Hiroko Minatogawa, Takako Eguchi Nakajima, Hirotoshi Iihara et al.|British Journal of Cancer|2023Cited by 18
Effectiveness of Statins for Oxaliplatin‐Induced Peripheral Neuropathy: A Multicenter Retrospective Observational StudyKenshi Takechi, Keisuke Ishizawa, Takehiro Kawashiri et al.|Clinical and Translational Science|2025Cited by 1